Meadow Brook Investment Advisors LLC Abb Vie Inc. Transaction History
Meadow Brook Investment Advisors LLC
- $106 Billion
- Q2 2024
A detailed history of Meadow Brook Investment Advisors LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Meadow Brook Investment Advisors LLC holds 801 shares of ABBV stock, worth $155,009. This represents 0.13% of its overall portfolio holdings.
Number of Shares
801
Previous 801
-0.0%
Holding current value
$155,009
Previous $146 Million
5.81%
% of portfolio
0.13%
Previous 0.14%
Shares
2 transactions
Others Institutions Holding ABBV
# of Institutions
3,689Shares Held
1.27BCall Options Held
13MPut Options Held
9.79M-
Vanguard Group Inc Valley Forge, PA171MShares$33 Billion0.57% of portfolio
-
Black Rock Inc. New York, NY136MShares$26.4 Billion0.54% of portfolio
-
State Street Corp Boston, MA77.8MShares$15.1 Billion0.59% of portfolio
-
Jpmorgan Chase & CO New York, NY53.6MShares$10.4 Billion0.81% of portfolio
-
Capital International Investors Los Angeles, CA38.6MShares$7.47 Billion1.4% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $342B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...